28 Feb Focus on EMBO team 1 article on glioblastoma

Posted at 16:44h in News by

Researchers from the team 1 (Tumor and vascular biology laboratory), in collaboration with researchers from the IBGC (CNRS / Université de Bordeaux) have published their work in the prestigious journal EMBO Molecular Medicine.

This work highlights the potential of mubritinib to target a metabolic vulnerability in cancer cells and boost the efficacy of existing treatments for glioblastoma.

Read the SBM Department’s article about this publication!

Read the SBM Department FOCUS
Read the publication on EMBO

Thank you to all those who supported and financed this work : Fondation de France, Cancéropôle GSO, ARTC, INCa, ANR